Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
KBG Foundation Partners with FDNA to Help Children with Rare Genetic Diseases
MANCHESTER, Md.–(BUSINESS WIRE)– “Today, KBG Foundation announces its partnership with Boston-based FDNA to accelerate precision medicine and grow the number of confirmed KBG global cases. Clinicians working with the KBG Foundation helped to train FDNA’s facial analysis technology, Face2Gene, to better recognize the clinical signs of KBG Syndrome in patients. The results from this work are now being made available to experts globally to better diagnose and treat patients suffering from KBG.”
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…